UPDATE 1-Novo Nordisk's Q2 profit beats forecasts, raises outlook

(Adds adjusted profit, background in paragraphs 3-7) COPENHAGEN, Aug 4 (Reuters) – Novo Nordisk, the maker of weight-loss drug Wegovy, reported a second-quarter adjusted operating profit above

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)